Dr. Grzegorz Wesela-Bauman

Daniel Larcombe-Young

Dr. Stefan Horstmann

Dr. Stefan Horstmann is VP of PS Core - Patents and Scientific Services at Merck KGaA.

Dr. Horstmann holds a PhD in Chemistry and is qualified as European and German Patent Attorney. Before becoming a VP of PS Core, he previously served as Head of the Patents B2B Department, and has also served as in-house patent attorney at Merck KGaA and Henkel KGaA and as an IT consultant at SerCon GmbH.

Dr. Horstmann is a member of the European Patent Institute (EPI), the German Chemical Society (GDCh) and the Association of Intellectual Property Experts (VPP). He represents Merck to matters of intellectual property law at the European Chemical Industry Council (CEFIC) and the German Chemical Industry Association (VCI).

James Lederer

Tilman Breitenstein

Timothy Sousa

Charles Leonardi

Bastien Sachet

David Holland

David is a Partner in Carpmaels’ Life Sciences group. He has been leading the firm’s UPC preparations since the early excitement about the new patent system back in 2014. His practice focuses on managing interrelated oppositions and appeals at the EPO, with a particular focus on platform protection and freedom to operate. David regularly supports pan-European litigation with the Carpmaels’ Dispute Resolution team, so he has seen the pros and cons of the current patchwork of national courts first hand. He expects the UPC to provide a valuable forum for disputes as the new system comes to life. David is often asked to share his UPC expertise, both through industry-wide events and also as a guest lecturer at the Industrial Property Course held by the Politecnico di Milano which entitles European patent attorneys to act before the UPC.